Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial

Abhishek, A; Boyton, RJ; Peckham, N; McKnight, Á; Coates, LC; Bluett, J; Barber, V; Cureton, L; Francis, A; Appelbe, D; Eldridge, L; Julier, P; Valdes, AM; Brooks, T; Rombach, I; Altmann, DM; Nguyen-Van-Tam, JS; Williams, HC; Cook, JA

COVID-19 Collection

Journal article

Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial

Abstract:: Background
Immunosuppressive treatments inhibit vaccine-induced immunity against SARS-CoV-2. We evaluated whether a 2-week interruption of methotrexate treatment immediately after the COVID-19 vaccine booster improved antibody responses against the S1 receptor-binding domain (S1-RBD) of the SARS-CoV-2 spike protein compared with uninterrupted treatment in patients with immune-mediated inflammatory diseases.
Methods
We did an open-label, prosp... Expand abstract
Collapse abstract

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Abhishek, A., Boyton, R. J., Peckham, N., McKnight, Á., Coates, L. C., Bluett, J., Barber, V., Cureton, L., Francis, A., Appelbe, D., Eldridge, L., Julier, P., Valdes, A. M., Brooks, T., Rombach, I., Altmann, D. M., Nguyen-Van-Tam, J. S., Williams, H. C., & Cook, J. A. (2022). Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial. The Lancet. Respiratory Medicine, 10(9), 840–850.

MLA Style

Abhishek, A, et al. “Effect of a 2-Week Interruption in Methotrexate Treatment versus Continued Treatment on COVID-19 Booster Vaccine Immunity in Adults with Inflammatory Conditions (VROOM Study): a Randomised, Open Label, Superiority Trial.” The Lancet. Respiratory Medicine, vol. 10, no. 9, 2022, pp. 840–50.

Chicago Style

Abhishek, A, RJ Boyton, N Peckham, et al. 2022. “Effect of a 2-Week Interruption in Methotrexate Treatment versus Continued Treatment on COVID-19 Booster Vaccine Immunity in Adults with Inflammatory Conditions (VROOM Study): a Randomised, Open Label, Superiority Trial.” The Lancet. Respiratory Medicine 10 (9): 840–50.
Print